An interventional study of Decreased Physical Activity and Increased Physical activity in Sedentary Behavior, Metabolic Syndrome and Age-related Cognitive Decline, sponsored by University of Nottingham. Recruiting at 1 site in United Kingdom. Open to participants aged 50 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-04.
Sponsored by University of Nottingham · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Sedentary Behavior with a site in United Kingdom — 10 open to participants now, 10 under way, none of them phase 3. Sedentary Behavior · United Kingdom.
Among the 52 studies in Sedentary Behavior with a site in United Kingdom, this one is the 18th largest by planned enrollment of the 48 interventional ones that give a count, is one of 6 that started in 2024, is one of 47 with no phase, and was the 45th registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →10 of the 52 studies in Sedentary Behavior with a site in United Kingdom are open now. Recruiting first, the newest first:
Canterbury Christ Church University · Sites in United Kingdom
Ages 18–55 · Healthy volunteers
University of Vic - Central University of Catalonia · Sites in United Kingdom, Lithuania, Spain
Ages 50–100
University of Leicester · Sites in United Kingdom
Ages 18–75
University of Southampton · Sites in United Kingdom
Ages 65+ · Healthy volunteers
University of Ulster · Sites in United Kingdom
Ages 10–14 · Healthy volunteers
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 50 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 6 started in 2024.
This study's planned enrollment of 40 is below the median of 60 across 1,077 interventional studies indexed under Sedentary Behavior.
Median enrollment 34 across the 48 interventional studies, 178 across the 4 observational. Of the 35 that completed or were terminated, 3 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 52 has an industry lead sponsor. The 10 most frequent:
University of Nottingham is the lead sponsor of 465 studies on the registry; 80 are open to participants now.
University of Nottingham has 4 studies filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
2 of the studies in Sedentary Behavior with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06017934University of SouthamptonPromoting Increased Physical Activity in Hospitalised Older Adults | 2026-11 |
| NCT06583733University of Vic - Central University of CataloniaKeep On Keep Up Bladder Health: Co-creating and Testing a Self-management Technological Solution for Ageing Well | 2027-08-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 52 studies in Sedentary Behavior with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Life expectancy has been increasing for the last 150 years, but the maintenance of health has not kept pace with increased lifespan, and on average, UK adults spend the last decade of life in poor-health, with major consequences for society and the individual.
Persistent physical inactivity is thought to be a key contributing factor to the risk of poor health and functional decline occurring in middle-aged and older adults. It is therefore concerning that most middle-aged adults spend >8hrs/day being sedentary, with average step count of 3000-4000 steps/day.
To be able to holistically assess the effectiveness of future strategies to address age-related decline in health, and devise public health messages to help individuals reach older age in better health, it is essential that the complex physiological effects that activity and inactivity have across biological systems are characterised.
The goal of this intervention study is to compare the impact of physical activity and inactivity on body functioning. Twenty moderately active participants will decrease their physical activity for three months to match the average amount carried out by middle-aged people in the UK. They will then undertake 3-months of reconditioning training to restore their fitness. In addition, twenty sedentary participants will increase their physical activity to UK recommended levels for six months.
Before and at points during the intervention period, participants will be asked to make some measurements at home and attend the University of Nottingham to have multiple assessments made. These include;
This 5-year study will commence in January 2024, with participant recruitment starting in March 2024 and finishing in May 2027.
This is a parallel design study comparing the impact of physical activity and inactivity on the way the body functions, to understand the mechanisms (including the inter-relationship between tissues and organs) by which lifestyle behaviours may effect health and wellbeing in later life. In particular, the mechanisms by which inactivity results in long term poor health is not well understood, and has rarely been studied in an integrated way in people. However, initial research indicates that the physiology of being inactive is not simply the reverse of being active. To enable effective treatments and public health advice to be devised so that more adults reach old age in better health, and maintain a good quality of life for a greater proportion of their older age, it is important that the impact of physical inactivity on the way the body functions is better understood. Therefore, twenty participants who are moderately, but not highly active will be asked to decrease their physical activity for three months to match the average exercise levels of middle-aged people in the United Kingdom (UK). This will require them to increase their daily sitting time to 7 hours a day and reduce their step count to \<4500 steps per day. At the end of the 3-months they will undertake 3-months of supervised reconditioning training by attending the Medical School at Queen's Medical Centre, Nottingham, three times a week.
In addition, twenty participants who currently have low physical activity levels will be asked to increase their physical activity to UK recommended levels by attending the Medical School at Queen's Medical Centre, Nottingham, three times a week for six months to undertake a supervised exercise program.
Before and during the 6-month period (at weeks 6, 12, 18 and 24) participants will be asked to make some measurements at home (physical activity levels, dietary intake) and attend the University of Nottingham over 4 days to have multiple assessments made. These include: height; weight; body composition (body fat and lean tissue); blood pressure; fitness, muscle strength and function; sleep quality, quality of life and wellbeing (questionnaires). The rate of muscle protein breakdown and muscle protein synthesis, blood sugar regulation, and biochemistry of the blood, fat tissue and muscles will be assessed, and to enable this muscle and fat tissue biopsies will be collected and blood samples taken. The study also involves having MRI scans to study the structure and function of the brain and heart, and to determine liver and muscle fat content.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will reduce their physical activity (increase sitting time to 7hrs/day and decrease step count to \<4500/day) for 3 months, then increase their activity for 3 months, through attending 3x 45 min supervised exercise sessions/week.
Behavioral: Decreased Physical Activity
Participants in this group will have moderate intensity physical activity levels increased for 6 months, through attending 3x 45 min supervised exercise sessions/week.
Behavioral: Increased Physical activity
Physical activity levels will be decreased
Physical activity levels will be increased
Change in Cardiorespiratory fitness (VO2 max)
change in maximal oxygen uptake (continuous incremental bicycle ergometer exercise test with on-line gas analysis) measured every 6 weeks
Time frame: 12 weeks
Change in Isometric leg strength
Change in Isometric leg strength measured every 6 weeks using CYBEX dynamometer
Time frame: 24 weeks
Change in time to leg fatigue
Change in time taken to induce muscle fatigue measured every 6 weeks using isokinetic knee extensions on a CYBEX dynamometer
Time frame: 24 weeks
Change in incremental area under the curve (iAUC) for blood glucose concentration
Change in 180 minute blood glucose concentration incremental area under the curve measured every 6 weeks during an oral glucose tolerance test.
Time frame: 24 weeks
Change in iAUC for serum insulin concentration
Change in 180-minute serum insulin concentration incremental area under the curve measured every 6 weeks during an oral glucose tolerance test
Time frame: 24 weeks
Change in fasting glucose oxidation rate
Change in glucose oxidation rate (when fasted), measured every 6 weeks using ventilated hood indirect calorimetry
Time frame: 24 weeks
Change in 'fed' glucose oxidation rate
Change in glucose oxidation rate (in the insulin-stimulated 'fed' state), measured every 6 weeks using ventilated hood indirect calorimetry during an oral glucose tolerance test
Time frame: 24 weeks
Change in Short Form Health Survey (SF36) Questionnaire aggregated normalised 'physical' score
Change in 'SF36' Questionnaire aggregated 'physical' score (normalised to UK population) calculated according to standard procedures (min 0, max 100), with higher score indicating better physical wellbeing measured every 6 weeks
Time frame: 24 weeks
Change in Short Form Health Survey (SF36) Questionnaire aggregated and normalised 'mental' score
Change in 'SF36' Questionnaire aggregated 'mental' score (normalised to UK population) calculated according to standard procedures (min 0, max 100), with higher score indicating better mental wellbeing, measured every 6 weeks
Time frame: 24 weeks
Change in World Health Organisation Quality of Life (WHOQoL) score
Change in World Health Organisation Quality of Life Score (measured using the WHOQoL-Bref questionnaire every 6 weeks), (min score 0, max 100), with higher score indicating a better state of health.
Time frame: 24 weeks
Change in Pittsburgh Sleep Quality Index (PSQI)
Change in PSQI score (min score 0, max 21), measured every 6 weeks, with higher score indicating poorer sleep quality
Time frame: 24 weeks
Change in Stroop test; % Accuracy
Change in the percentage of accurate responses, measured every 6 weeks, with higher score indicating better cognitive performance. Minimum value 0%, maximum value 100%
Time frame: 24 weeks
Change in Stroop test; reaction time
Change in the reaction time for responses, measured every 6 weeks, with higher score indicating slower cognitive performance. No minimum or maximum value defined.
Time frame: 24 weeks
Change in four-choice reaction time test; % Accuracy
Change in the percentage of accurate responses, measured every 6 weeks, with higher score indicating better cognitive performance. Minimum value 0%, maximum value 100%
Time frame: 24 weeks
Change in four-choice reaction time test; reaction time
Change in the reaction time for responses, measured every 6 weeks, with higher score indicating slower cognitive performance. No minimum or maximum value defined.
Time frame: 24 weeks
Change in card sort test; % Accuracy
Change in the percentage of accurate responses, measured every 6 weeks, with higher score indicating better cognitive performance. Minimum value 0%, maximum value 100%
Time frame: 24 weeks
Change in card sort test; reaction time
Change in the reaction time for responses, measured every 6 weeks, with higher score indicating slower cognitive performance. No minimum or maximum value defined.
Time frame: 24 weeks
Change in Logical reasoning test; % accuracy
Change in the accuracy of responses, measured every 6 weeks, with higher score indicating better cognitive performance. Minimum value 0%, maximum value 100%
Time frame: 24 weeks
Change in Logical reasoning test; reaction time
Change in the reaction time for responses, measured every 6 weeks, with higher score indicating slower cognitive performance. No minimum or maximum value defined.
Time frame: 24 weeks
Change in serial subtractions test; number of responses in 2 minutes
Change in the number of responses, measured every 6 weeks, with higher score indicating better cognitive performance. minimum number is 0, maximum number is variable dependent on starting value (800-999; randomly selected by computer program) and speed of response.
Time frame: 24 weeks
Change in Corsi blocks test; score
Change in the test score, measured every 6 weeks, with higher score indicating better cognitive performance.Minimum score is 0 and maximum is 15.
Time frame: 24 weeks
Change in Muscle protein synthesis rate
Muscle synthesis protein rate calculated from deuterium incorporation into muscle tissue
Time frame: 24 weeks
Change in Muscle protein breakdown rate
Muscle protein breakdown rate calculated every 6 weeks using 3-methylhistidine tracer
Time frame: 24 weeks
Change in whole body fat volumes
Change in the amount of fat within the body, measured every 6 weeks using magnetic resonance imaging (MRI)
Time frame: 24 weeks
Change in liver fat volumes
Change in the amount of fat within the liver, measured every 6 weeks using magnetic resonance imaging (MRI)
Time frame: 24 weeks
Change in thigh muscle fat volumes
Change in the amount of fat within the vastus lateralis thigh muscle, measured every 6 weeks using magnetic resonance imaging (MRI)
Time frame: 24 weeks
Change in whole body muscle volumes
Change in the amount of muscle within the body, measured every 6 weeks using magnetic resonance imaging (MRI)
Time frame: 24 weeks
Change in muscle phosphocreatine synthesis rate
Change in the rate of phosphocreatine synthesis, measured every 6 weeks using magnetic resonance spectroscopy
Time frame: 24 weeks
Change in cerebral volume
Change in the volume of brain tissue, measured every 6 weeks using magnetic resonance imaging (MRI)
Time frame: 24 weeks
Change in cortical thickness
Change in the thickness of the brain cortex, measured every 6 weeks using magnetic resonance imaging (MRI)
Time frame: 24 weeks
Change in plasma metabolome
change in untargeted plasma metabolome profile measured every 6 weeks
Time frame: 24 weeks
Fasting blood lipid concentration
concentration of lipid within the blood
Time frame: pre-intervention
Fasting blood lipid concentration
concentration of lipid within the blood
Time frame: 6 weeks
Fasting blood lipid concentration
concentration of lipid within the blood
Time frame: 12 weeks
Fasting blood lipid concentration
concentration of lipid within the blood
Time frame: 18 weeks
Fasting blood lipid concentration
concentration of lipid within the blood
Time frame: 24 weeks
liver function test: alanine transaminase (ALT)
concentration of ALT measured on blood sample
Time frame: pre-intervention
liver function test: alanine transaminase (ALT)
concentration of ALT measured on blood sample
Time frame: 6 weeks
liver function test: alanine transaminase (ALT)
concentration of ALT measured on blood sample
Time frame: 12 weeks
liver function test: alanine transaminase (ALT)
concentration of ALT measured on blood sample
Time frame: 18 weeks
liver function test: alanine transaminase (ALT)
concentration of ALT measured on blood sample
Time frame: 24 weeks
liver function test: aspartate aminotransferase (AST)
concentration of AST measured on blood sample
Time frame: pre-intervention
liver function test: aspartate aminotransferase (AST)
concentration of AST measured on blood sample
Time frame: 6 weeks
liver function test: aspartate aminotransferase (AST)
concentration of AST measured on blood sample
Time frame: 12 weeks
liver function test: aspartate aminotransferase (AST)
concentration of AST measured on blood sample
Time frame: 18 weeks
liver function test: aspartate aminotransferase (AST)
concentration of AST measured on blood sample
Time frame: 24 weeks
liver function test: Bilirubin
concentration of bilirubin measured on blood sample
Time frame: pre-intervention
liver function test: Bilirubin
concentration of bilirubin measured on blood sample
Time frame: 6 weeks
liver function test: Bilirubin
concentration of bilirubin measured on blood sample
Time frame: 12 weeks
liver function test: Bilirubin
concentration of bilirubin measured on blood sample
Time frame: 18 weeks
liver function test: Bilirubin
concentration of bilirubin measured on blood sample
Time frame: 24 weeks
liver function test: Albumin
concentration of albumin measured on blood sample
Time frame: pre-intervention
liver function test: Albumin
concentration of albumin measured on blood sample
Time frame: 6 weeks
liver function test: Albumin
concentration of albumin measured on blood sample
Time frame: 12 weeks
liver function test: Albumin
concentration of albumin measured on blood sample
Time frame: 18 weeks
liver function test: Albumin
concentration of albumin measured on blood sample
Time frame: 24 weeks
liver function test: Gamma glutamyl transferase (GGT)
concentration of GGT measured on blood sample
Time frame: pre-intervention
liver function test: Gamma glutamyl transferase (GGT)
concentration of GGT measured on blood sample
Time frame: 6 weeks
liver function test: Gamma glutamyl transferase (GGT)
concentration of GGT measured on blood sample
Time frame: 12 weeks
liver function test: Gamma glutamyl transferase (GGT)
concentration of GGT measured on blood sample
Time frame: 18 weeks
liver function test: Gamma glutamyl transferase (GGT)
concentration of GGT measured on blood sample
Time frame: 24 weeks
Blood Haemoglobin concentration
haemoglobin concentration measured on a blood sample
Time frame: pre intervention
Blood Haemoglobin concentration
haemoglobin concentration measured on a blood sample
Time frame: 6 weeks
Blood Haemoglobin concentration
haemoglobin concentration measured on a blood sample
Time frame: 12 weeks
Blood Haemoglobin concentration
haemoglobin concentration measured on a blood sample
Time frame: 18 weeks
Blood Haemoglobin concentration
haemoglobin concentration measured on a blood sample
Time frame: 24 weeks
Plan to share: Yes — Anonymised dataset will be made available to other researchers on request after study aims have been analysed and published. No patient identifiable data will be shared
Supporting information: Study protocol, Statistical analysis plan, Clinical study report
Time frame: Data will become available approximately 2 years after study completion and will be available for 20 years
Access criteria: Although parts of the data set generated from this project will be available on open access platforms to support publications, access to the full data repository and tissue archive will be through requests made to the Management Board. Access will be subject to ethical constraints, the preservation of intellectual property (IP), and written acknowledgement that it is a research collaboration, with data ownership residing with the original research teams. Data will be shared subject to a data transfer agreement and confirmation that deletion of the shared data set will occur once analysis has been completed.
No publications or documents are linked to this record.
Started Mar 2024 (actual). Primary completion is estimated for Dec 2027, 45 months after the start.
Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 45 months is above that.
Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.